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transduction pathways: competition for recruitment of the Arnt
transcription factor
Abstract
Hypoxia-inducible factor 1 alpha (HIF-1 alpha) and the intracellular dioxin receptor mediate hypoxia
and dioxin signalling, respectively. Both proteins are conditionally regulated basic helix-loop-helix
(bHLH) transcription factors that, in addition to the bHLH motif, share a Per-Arnt-Sim (PAS) region of
homology and form heterodimeric complexes with the common bHLH/PAS partner factor Arnt. Here
we demonstrate that HIF-1 alpha required Arnt for DNA binding in vitro and functional activity in vivo.
Both the bHLH and PAS motifs of Arnt were critical for dimerization with HIF-1 alpha. Strikingly,
HIF-1 alpha exhibited very high affinity for Arnt in coimmunoprecipitation assays in vitro, resulting in
competition with the ligand-activated dioxin receptor for recruitment of Arnt. Consistent with these
observations, activation of HIF-1 alpha function in vivo or overexpression of HIF-1 alpha inhibited
ligand-dependent induction of DNA binding activity by the dioxin receptor and dioxin receptor function
on minimal reporter gene constructs. However, HIF-1 alpha- and dioxin receptor-mediated signalling
pathways were not mutually exclusive, since activation of dioxin receptor function did not impair HIF-1
alpha-dependent induction of target gene expression. Both HIF-1 alpha and Arnt mRNAs were
expressed constitutively in a large number of human tissues and cell lines, and these steady-state
expression levels were not affected by exposure to hypoxia. Thus, HIF-1 alpha may be conditionally
regulated by a mechanism that is distinct from induced expression levels, the prevalent model of
activation of HIF-1 alpha function. Interestingly, we observed that HIF-1 alpha was associated with the
molecular chaperone hsp90. Given the critical role of hsp90 for ligand binding activity and activation of
the dioxin receptor, it is therefore possible that HIF-1 alpha is regulated by a similar mechanism,
possibly by binding an as yet unknown class of ligands.
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Hypoxia-inducible factor 1a (HIF-1a) and the intracellular dioxin receptor mediate hypoxia and dioxin
signalling, respectively. Both proteins are conditionally regulated basic helix-loop-helix (bHLH) transcription
factors that, in addition to the bHLH motif, share a Per-Arnt-Sim (PAS) region of homology and form
heterodimeric complexes with the common bHLH/PAS partner factor Arnt. Here we demonstrate that HIF-1a
required Arnt for DNA binding in vitro and functional activity in vivo. Both the bHLH and PAS motifs of Arnt
were critical for dimerization with HIF-1a. Strikingly, HIF-1a exhibited very high affinity for Arnt in coim-
munoprecipitation assays in vitro, resulting in competition with the ligand-activated dioxin receptor for
recruitment of Arnt. Consistent with these observations, activation of HIF-1a function in vivo or overexpres-
sion of HIF-1a inhibited ligand-dependent induction of DNA binding activity by the dioxin receptor and dioxin
receptor function on minimal reporter gene constructs. However, HIF-1a- and dioxin receptor-mediated
signalling pathways were not mutually exclusive, since activation of dioxin receptor function did not impair
HIF-1a-dependent induction of target gene expression. Both HIF-1a and Arnt mRNAs were expressed con-
stitutively in a large number of human tissues and cell lines, and these steady-state expression levels were not
affected by exposure to hypoxia. Thus, HIF-1a may be conditionally regulated by a mechanism that is distinct
from induced expression levels, the prevalent model of activation of HIF-1a function. Interestingly, we
observed that HIF-1a was associated with the molecular chaperone hsp90. Given the critical role of hsp90 for
ligand binding activity and activation of the dioxin receptor, it is therefore possible that HIF-1a is regulated
by a similar mechanism, possibly by binding an as yet unknown class of ligands.
Hypoxia-inducible factor 1a (HIF-1a) has recently been re-
ported to mediate transcriptional responses to hypoxia by
binding to hypoxia-inducible enhancer motifs (hypoxia re-
sponse elements [HREs]) of target genes (56). HRE core se-
quences are asymmetric E-box motifs that have been charac-
terized in the erythropoietin (EPO) gene (50) and genes
encoding vascular endothelial growth factor (VEGF) (14, 27)
and a number of glycolytic enzymes (13, 14, 27, 49). HIF-1a
binds HRE motifs as a heterodimeric complex, termed HIF-1,
with the transcription factor Arnt (56). Both HIF-1a and Arnt
are members of a novel subclass of the basic helix-loop-helix
(bHLH) family of transcription factors. Members of this class
of factors are characterized by a bHLH motif contiguous with
a region, PAS (Per-Arnt-Sim), which is conserved between the
Drosophila neuronal cell developmental regulator Sim, the
Drosophila circadian rhythm regulatory protein Per, the
2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) (aryl hydrocar-
bon) receptor, and Arnt (for a recent review, see reference 29).
In addition, the Drosophila developmental factor trachealess
(22, 69) and a putative Down’s syndrome-critical factor (11)
have recently been shown to belong to the bHLH/PAS family
of gene-regulatory factors.
Whereas Arnt is a nuclear protein (20, 43) that constitutively
activates promoters driven by the dyad symmetry CACGTG
E-box element (2, 53), the intracellular dioxin receptor func-
tions as a ligand-activated transcription factor that mediates
the metabolic, toxic, and possibly carcinogenic effects of poly-
cyclic aromatic hydrocarbons and halogenated aromatic hydro-
carbons, most notably dioxin (reviewed in references 17 and
41). Upon exposure to ligand, the dioxin receptor dimerizes
with Arnt, enabling both proteins to recognize an asymmetric
E-box motif of xenobiotic response elements (XREs) that are
distinct from the HRE motif (25, 47, 66).
In the absence of ligand, the dioxin receptor is recovered as
a non-DNA-binding protein in cytosolic cellular extracts as a
;300-kDa heteromeric complex stably associated with the mo-
lecular chaperone hsp90 (reference 68 and references therein).
hsp90 is critical for folding of a ligand-binding conformation of
the receptor in vitro (3, 10, 44) and for ligand inducibility in
vivo (8, 65). Dioxin and other known ligands induce nuclear
translocation of the dioxin receptor (references 23 and 43 and
references therein) and regulate dimerization with Arnt (66).
In the ligand-induced receptor activation process, release of
hsp90 appears to be necessary to unmask functional activities
of the receptor protein (66, 68). Ligand (63) and hsp90 (63)
binding activities are colocalized within the C-terminal half of
the PAS domain of the dioxin receptor. In contrast, Arnt is not
associated with hsp90 but may play an active role in release of
hsp90 from the ligand-activated dioxin receptor (35, 36). All
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known ligands of the dioxin receptor, e.g., the environmental
pollutant dioxin and indolo[3,3-b]carbazole derivatives that
represent very potent receptor agonists occurring in the diet
(24, 46), are of xenobiotic origin. Thus, the existence of a
physiological receptor ligand remains an enigma (reviewed in
reference 42). Interestingly, however, targeted disruption of
the mouse dioxin receptor gene has indicated that the receptor
plays an important role in hepatic and possibly lymphoid de-
velopment (12).
In our efforts to understand the mechanism of regulation of
bHLH/PAS transcription factors, we demonstrate here that
Arnt is critical for both dioxin receptor- and HIF-1a-mediated
signalling pathways. Functionally HIF-1a dominated over the
dioxin receptor, resulting in competition for recruitment of
Arnt in vitro and negative regulation of dioxin receptor-medi-
ated signalling in hepatoma cells. In contrast to the proposed
model of activation of HIF-1a (56), HIF-1a and Arnt mRNA
steady-state levels were not induced by exposure to hypoxia.
Thus, HIF-1a may be conditionally regulated by a distinct
mechanism, possibly by functioning as an orphan receptor
binding an as yet unknown class of ligands. In support of this
model, HIF-1a was found to be stably associated with the
molecular chaperone hsp90 that is critical for ligand binding
activity and conditional regulation of the dioxin receptor.
MATERIALS AND METHODS
Recombinant plasmids. Plasmids containing full-length Arnt (pArnt/GEM7)
and the Arnt deletion mutants pArntDbHLH/GEM7, pArntDb/GEM7, and
pArntDPAS/GEM7 have been previously described (28, 36, 66). pDR/ATG/
psp72 was obtained by subcloning an XhoI-HindIII fragment containing full-
length murine dioxin receptor cDNA from pDR/ATG/BS (36) into
XhoI-HindIII-digested psp72 (Promega). The reporter gene constructs pT81
(38), pTX.Dir (4), and pGLHIF1.3 (25) have been described previously. HIF-1a
cDNA (56) was cloned by reverse transcription followed by PCR of total HeLa
RNA and subcloned into pBS (Stratagene), generating pHIF-1a/BS. Nucleotide
sequence was confirmed by sequencing. pHIF-1a/psp72 was obtained by insert-
ing a BamHI-ClaI fragment containing full-length HIF-1a cDNA into BamHI-
ClaI-digested psp72. pHIF-1a/CMV4 was generated by inserting a BamHI-ClaI
fragment of pHIF-1a/BS into BglII-ClaI-digested pCMV4 (1). pDR/CMV4,
pArnt/CMV4, and pArntDb/CMV4 have been described previously (28, 33).
Cell culture and treatments. The human hepatoma cell line HepG2 was grown
in Dulbecco’s modified Eagle’s medium (DMEM; Gibco-BRL) containing 10%
fetal calf serum (Gibco-BRL), 100 mg of streptomycin per ml, 100 IU of peni-
cillin (Gibco-BRL) per ml, and 0.25 mg of amphotericin B (Fungizone; Gibco-
BRL) per ml. HeLa cells were cultured in high-glucose DMEM supplemented as
described above. Cultures were treated with CoCl2 or 2,3,7,8-tetrachlorodiben-
zofuran (TCDF; Cambridge Isotope Laboratories), both dissolved in dimethyl
sulfoxide (DMSO), whereas control cultures received solvent only, not exceeding
a final concentration of 0.1% (vol/vol). Hepa 1c1c7 (Hepa 1) cells and the
Arnt-deficient subline Hepa 1C4 (19) were cultured in DMEM with the supple-
ments described above and 13 minimal essential medium containing nonessen-
tial amino acids, 2 mM L-glutamine, and 1 mM sodium pyruvate. Oxygen tensions
in the incubator were either 140 mm Hg (20% O2 [vol/vol]; normoxia) or 7 mm
Hg (1% O2 [vol/vol]; hypoxia). Cells were subjected to hypoxic induction at 70 to
80% confluency. HeLaS3 (ATCC CCL-2.2), a subline of HeLa adapted to
growth in suspension, was cultured in Ham’s F-12 medium (Gibco-BRL) sup-
plemented as described above. Hypoxic induction was achieved by incubation of
HeLaS3 cells at a density of 107 cells per ml in an IL 237 tonometer (Instru-
mentation Laboratories) under continuous stirring for 4 h at 378C, using a gas
mixture of either 20% O2, 5% CO2, and 75% N2 (normoxia) or 1% O2, 5% CO2,
and 94% N2 (hypoxia), respectively, at a flow rate of 500 ml/min. All chemicals,
medium, and growth factors were purchased from Sigma unless stated otherwise.
RNA isolation and Northern (RNA) blot analysis. Total RNA was isolated by
acid-phenol extraction as described previously (9), and mRNA levels were as-
sayed by Northern blot analysis using standard procedures (48). cDNAs for
fructose-1,6-bisphosphate aldolase A (60), VEGF (59), ribosomal protein L28
(59), EPO (60), mouse dioxin receptor (6), human Arnt (19), P-4501A1 (15),
b-actin (Clontech), and HIF-1a were used as probes. The human multiple-tissue
RNA blot was obtained from Clontech. 32P-labeled probes were generated by a
random priming procedure. RNA filters were prehybridized, hybridized, and
washed according to standard procedures (48) prior to autoradiography. Two
Arnt RNA species were detected as previously reported (19). The radioactive
signals were recorded and quantified with a phosphor imager (Fuji).
Transfection and transient expression assays. HepG2 cells were incubated
overnight in DMEM lacking serum with 1.2 mg of cationic liposomes (Lipofectin;
Gibco-BRL) per cm2 and plasmid DNA. The medium was then changed to
DMEM supplemented with 10% serum (Gibco-BRL), and the cells were subse-
quently treated with either 150 mM CoCl2, 50 nM TCDF, or DMSO alone for 36
to 48 h prior to harvest. In indicated experiments, HepG2 cells were transfected
with 0.1 mg of pTX.Dir per cm2 either alone or with 0.2 mg of pCMV/HIF-1a per
cm2. HeLa cells were transfected by a CaPO4 precipitation method (15). The
cells were incubated with the DNA-CaPO4 solution for 16 to 20 h prior to
treatment with 50 nM TCDF or DMSO alone for an additional 36 to 48 h. HeLa
cells were cotransfected with either pTX.Dir (0.1 mg/cm2) or pGLHIF1.3 (0.2
mg/cm2) and a combination of pCMV4 expression vectors for the dioxin receptor,
HIF-1a, Arnt, and ArntDb. The luciferase assay was performed as described
previously (48), with the modification that the cells were lysed on ice by a brief
treatment in a sonicator. Luciferin was purchased from BioThema.
Cell extract preparation and electrophoretic mobility shift assay. Nuclear
extracts were prepared from normoxic or hypoxic HeLa and Hepa 1 cells as
described previously (25); 4 to 5 mg of nuclear extract was incubated with an EPO
HRE probe (25) for 20 min at 48C in a total volume of 20 ml containing 0.1 mg
of sonicated, denatured calf thymus DNA in 10 mM Tris-HCl (pH 7.5)–50 mM
KCl–50 mMNaCl–1 mMMgCl2–1 mM EDTA–5 mM dithiothreitol–5% glycerol
and separated on 4% polyacrylamide gels at 200 V in TBE buffer (89 mM Tris,
89 mM boric acid, 5 mM EDTA) at 48C. Human HepG2 cells were treated with
50 nM TCDF in the absence or presence of increasing concentrations of CoCl2
for the indicated period of time. Control cultures received DMSO for 1 h before
harvest. Nuclei were prepared and protein was extracted as described previously
(54). XRE binding reactions were assembled in a total volume of 20 ml with 10
mg of nuclear protein at final concentrations of 25 mM N-2-hydroxyethylpipera-
zine-N9-2-ethanesulfonic acid (HEPES; pH 7.9), 0.2 mM EDTA, 75 mM KCl, 2
mMMgCl2, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, 10 mg of
aprotinin (Bayer) per ml, 10 mg of leupeptin per ml, 5 mM pepstatin (Boehr-
inger), 5% glycerol, 4% Ficoll, 100 mg of poly(dI-dC) (Pharmacia) per ml, and
12.5 mg of poly(dA-dT) (Pharmacia) per ml, using a double-stranded, 32P-labeled
oligonucleotide as a probe, the sequence of which corresponded to positions
2968 to 2997 of the human CYPIA1 gene (59-CTCCGGTCCTTCTCACGCAA
CGCCTGGGCA-39, sense orientation). In competition experiments, a 100-fold
molar excess of unlabeled oligonucleotide (unspecific competitor described in
reference 15) was used. DNA-protein complexes were separated under nonde-
naturing conditions on a 4% polyacrylamide gel (29:1) run in 13 TGE buffer (50
mM Tris, 2.7 mM EDTA, 380 mM glycine) at 48C.
In vitro protein expression and coimmunoprecipitation experiments. Full-
length HIF-1a, dioxin receptor, and Arnt and the indicated Arnt deletion mu-
tants were translated in vitro either in the presence or in the absence of [35S]me-
thionine in rabbit reticulocyte lysate as recommended by the manufacturer
(Promega). [35S]methionine-labeled in vitro-synthesized products were analyzed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
fluorography. Analysis of unlabeled in vitro translation products was determined
by simultaneous incubation of an aliquot of the reaction in the presence of
[35S]methionine followed by SDS-PAGE and fluorography. Radiolabeled bands
were analyzed on a phosphor imager (Fuji); when required, equal protein con-
centrations for competition and comparative coimmunoprecipitation experi-
ments were calculated on the basis of incorporated [35S]methionine. Arnt coim-
munoprecipitation experiments were carried out as previously described (35).
Briefly, [35S]methionine-labeled in vitro-synthesized full-length HIF-1a or the
dioxin receptor was incubated with equal concentrations of unlabeled in vitro
synthesized Arnt or the Arnt deletion mutants as indicated in the figure legends.
Reaction volumes were corrected with blank translation mix, and incubation was
carried out at either 258C for 2 h or 48C overnight in the presence of 5 mg of each
of the protease inhibitors aprotinin, leupeptin, and pepstatin per ml and 1 mM
phenylmethylsulfonyl fluoride. Protein mixtures were precleared by incubation
with 10 ml of preimmune serum on ice for 15 min followed by a further 15-min
incubation with 50 ml of a 50% slurry of protein A-Sepharose in TEG buffer (20
mM Tris-HCl [pH 7.4], 1 mM EDTA, 10% [wt/vol] glycerol, 1 mM dithiothreitol)
containing 150 mMNaCl, 0.2% Triton X-100, and 1 mg of bovine serum albumin
per ml. Following rapid centrifugation, the resulting supernatants were incubated
with 10 ml of Arnt-specific antiserum (33) for 1 h at room temperature, 100 ml of
protein A-Sepharose (50% slurry as described above) was then added, and the
reaction mixtures were incubated on ice for 45 min. After rapid centrifugation,
the resulting Sepharose pellets were washed twice with 500 ml of supplemented
TEG buffer and once with buffer minus bovine serum albumin. Coimmunopre-
cipitated proteins were analyzed by SDS-PAGE and fluorography. hsp90 coim-
munoprecipitation was also carried out as previously described (35, 36). Briefly,
[35S]methionine-labeled in vitro-synthesized full-length HIF-1a was incubated
with Sepharose containing preadsorbed hsp90-specific monoclonal immunoglob-
ulin M antibody 3G3 (Affinity Bioreagents) or an equal concentration of control
mouse immunoglobulin M antibody TEPC 183 (Sigma) in MENG buffer (25 mM
morpholinepropanesulfonic acid [pH 7.5], 1 mM EDTA, 0.02% NaN3, 10%
glycerol) containing 20 mM molybdate, 2 mM dithiothreitol, and 2.5% (wt/vol)
bovine serum albumin on ice for 90 min. After centrifugation, the resulting
Sepharose pellets were washed four times with 1-ml aliquots of the above-
described immunoprecipitation buffer without bovine serum albumin, and the
coimmunoprecipitated products were analyzed by SDS-PAGE and fluorography.
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RESULTS
Ubiquitous and constitutive expression of HIF-1a and Arnt
in human tissues. In rodents, the dioxin receptor and Arnt
appear to be ubiquitously expressed transcription factors that
show a largely coordinated manner of expression, as assessed
by dioxin receptor ligand binding assays and analysis of dioxin
receptor and Arnt mRNA expression levels (reference 7 and
references therein). In the case of HIF-1a, it has been reported
that hypoxia induces expression in human Hep3B cells of
HIF-1a steady-state mRNA levels from very low background
values (56). We therefore wished to examine constitutive ex-
pression levels of HIF-1a mRNA in a variety of human tissue
samples and to compare these expression levels with those of
Arnt, the partner factor of HIF-1a. In RNA blot experiments,
we observed that Arnt mRNA was expressed in all tissues
examined. Relative to b-actin control mRNA levels, the high-
est Arnt mRNA expression levels were detected in the testis,
pancreas, ovary, and placenta, whereas low relative expression
levels were found in total brain RNA (Fig. 1). In analogy to
these results, HIF-1amRNA was constitutively expressed in all
tissues examined, with the highest relative expression levels in
the kidney, testis, and ovary. Moreover, liver, pancreas, and
lung tissues also showed high levels of HIF-1a mRNA expres-
sion. Thus, in contrast to human Hep3B cells (56), both Arnt
and HIF-1a mRNAs were constitutively expressed at signifi-
cant levels in human tissues, demonstrating a largely coordi-
nated expression pattern in a number of these tissues, e.g.,
testis, ovary, and pancreas. A notable exception to this expres-
sion pattern was found for skeletal muscle, where HIF-1a
mRNA levels were lower than Arnt mRNA levels (Fig. 1).
Arnt is critical for HIF-1a function. HIF-1a has been re-
ported to recognize HREs of target promoters as a het-
erodimeric complex with Arnt (56). To characterize the mech-
anism of signal transduction by HIF-1a, we initially examined
hypoxic regulation of target gene expression in wild-type Hepa
1 hepatoma cells and a subline thereof, Hepa 1C4, that ex-
presses functionally deficient Arnt (19). Consequently, in the
mutant Hepa 1C4 cells, the dioxin receptor cannot be con-
verted into an XRE-binding form although it exhibits bona fide
ligand binding properties (47, 66). In wild-type Hepa 1 cells,
exposure to low oxygen resulted in about fourfold induction of
VEGF mRNA levels, detected at 4 h after exposure, and a
twofold up-regulation of aldolase A mRNA levels following
16 h of exposure, as assessed by RNA blotting experiments
(Fig. 2A). Both the VEGF and aldolase A genes have been
reported to be regulated under hypoxic conditions by the HIF-
1a–Arnt complex via HRE motifs (49). In the case of the
VEGF gene, hypoxic induction has been reported to involve
mRNA stabilization (21, 26, 51), in addition to activation of
transcription by HIF-1a (27, 30, 49). In contrast to wild-type
Hepa 1 cells, exposure of the mutant Hepa 1C4 cells to hypoxia
FIG. 1. Distribution of HIF-1a and Arnt mRNAs in human tissues. Total
RNA from the indicated human tissues was used in RNA blotting experiments.
The same filter was subsequently hybridized with HIF-1a and Arnt cDNA probes
following 32P labeling by random priming. For a loading control, the filter was
analyzed for b-actin mRNA expression.
FIG. 2. Requirement of Arnt for hypoxic regulation of target genes. (A and B) RNA blot analysis of total RNA extracted from wild-type Hepa 1 or Arnt-deficient
Hepa 1C4 cells following simultaneous cultivation at either 20 or 1% oxygen for 4 and 16 h. The same filter was subsequently hybridized with the indicated cDNA probes
following 32P labeling by random priming. The signal obtained with the ribosomal protein L28 probe was used to correct for differences in loading and blotting. (C)
Electrophoretic gel mobility shift assay using nuclear extract prepared from HeLa, Hepa 1, or Hepa 1C4 cells cultured either in 20 or 1% oxygen for 4 h. An 18-bp
HRE oligonucleotide from the EPO gene was used as a probe. (D) To identify Arnt in the HIF-1 complex, nuclear extracts from Hepa 1 and Hepa 1C4 cells were
incubated with anti-Arnt antiserum prior to the DNA binding reaction. Note that the anti-Arnt antiserum recognized a single band in Hepa 1 cells.
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did not result in any induction of aldolase A mRNA expression
levels (Fig. 2A), demonstrating that Arnt is required for this
HIF-1a-mediated hypoxic response. Interestingly, however,
hypoxia induction of VEGF mRNA levels was only partially
impaired in mutant Hepa 1C4 cells relative to wild-type Hepa
1 cells, with an up to twofold induction response detected in
the mutant cells (Fig. 2A), indicating that the HIF-1a–Arnt
complex may only be partially involved in up-regulation of
VEGF expression under hypoxic conditions.
It has previously been reported that exposure to hypoxia or
CoCl2 induces HIF-1a mRNA levels in human Hep3B hepa-
toma cells from very low background levels following 2 to 4 h
of treatment (56). In contrast, in a number of human tissue
samples, we have observed constitutive expression levels of
HIF-1amRNA that were comparable to those of Arnt (Fig. 1).
Moreover, HIF-1a mRNA was constitutively expressed in
Hepa 1 cells (Fig. 2B). Importantly, we detected no induction
of HIF-1a mRNA expression by hypoxic treatment of these
cells, but rather down-regulation of the mRNA levels following
exposure to hypoxia (1% O2) for 16 h (Fig. 2B). These results
indicate that conditional regulation of HIF-1a function in
Hepa 1 cells may be attributed to a mechanism that is distinct
from induced HIF-1a expression levels observed in Hep3B
cells. For reference, dioxin receptor mRNA was expressed at
levels comparable to those of HIF-1a but unaffected by hy-
poxic treatment. Similarly, Arnt mRNA expression levels were
not altered by hypoxic treatment of Hepa 1 cells. Although
Hepa 1C4 cells are functionally Arnt deficient (19), Arnt
mRNA was also constitutively expressed in these cells, albeit at
levels much lower than those detected in wild-type cells (Fig.
2B). Interestingly, down-regulation of HIF-1a mRNA levels
was not detected in hypoxic Hepa 1C4 cells (Fig. 2B), raising
the possibility that negative feedback regulation of HIF-1a
mRNA expression involves functional Arnt protein.
In analogy to the observations in Hepa 1 cells, hypoxia
induction of HIF-1a mRNA levels was also not observed in a
large number of other cell lines, including human HepG2,
glioblastoma (LN229 and LN18) and B cells, mouse fibroblasts
(L929), embryonic stem cells (CCE1), primary mouse astro-
cytes, and primary rat mesangial cells (data not shown). In
summary, in contrast to the proposed model for regulation of
HIF-1a function in Hep3B cells (56), hypoxia induction of
HIF-1a and Arnt mRNA levels may not represent the primary
mechanism of conditional regulation of HIF-1a in these cell
lines.
As shown in electrophoretic mobility shift experiments (Fig.
2C; compare lanes 3 and 4), exposure of wild-type Hepa 1 cells
to hypoxia induced formation of a nuclear complex on an HRE
probe derived from the EPO gene (25). The induced complex
was specific for the HRE motif, as assessed by oligonucleotide
competition experiments (data not shown), and indistinguish-
able in relative mobility from the well-characterized (25, 57)
HIF-1 complex generated in control nuclear extracts from hy-
poxic HeLa cells (Fig. 2C; compare lanes 2 and 4). Moreover,
polyclonal anti-Arnt antibodies produced a supershift of this
complex (Fig. 2D). Formation of this complex was not induced
in nuclear extracts from mutant Hepa 1C4 cells grown under
hypoxic conditions (Fig. 2C and D). For reference, the consti-
tutive complex probably generated by the transcription factors
ATF-1 and CREB-1 with the EPO HRE probe (25) remained
unaffected upon exposure of the cells to hypoxia (Fig. 2C and
D). In analogy to the inability of Arnt and the dioxin receptor
to bind to the XRE motif alone (66), these results indicate that
HIF-1a failed to recognize the HRE motif individually. In
conclusion, Arnt-deficient, mutant Hepa 1C4 hepatoma cells
are nonresponsive with regard to not only dioxin receptor- but
also HIF-1a-mediated signalling pathways.
To investigate the functional activities of HIF-1a and Arnt
individually and in combination with one another, and to fur-
ther examine the role of Arnt in HIF-1a function, we per-
formed transient-transfection experiments using a luciferase
reporter gene, pGLHIF1.3 (25), that is driven by multimerized
copies of the HRE motif of the EPO gene coupled to the
simian virus 40 promoter (shown schematically in Fig. 3A).
This reporter gene showed moderate (about twofold) induc-
ibility by hypoxia (1% O2) following transient tranfection into
FIG. 3. Arnt is required for HIF-1a function. (A) HeLa cells were transiently cotransfected as described in Materials and Methods with pGLHIF1.3 and expression
vectors for HIF-1a, Arnt, and ArntDb. Luciferase activity was assayed after 48 h. (B) HeLa cells were transfected with the XRE-containing reporter gene pTX.DIR
and indicated expression plasmids. Luciferase activity obtained was determined following treatment with 50 nM TCDF for 48 h. The results show relative induction
obtained in cells transfected with expression plasmids relative to the activity obtained in cells transfected with the empty pCMV4 expression vector, and cell extracts
were normalized on the basis of protein content. Each bar represents the standard deviation of the relative induction obtained from three independent experiments.
SV40, simian virus 40; TK, thymidine kinase.
5224 GRADIN ET AL. MOL. CELL. BIOL.
wild-type Hepa 1 cells. This induction response was abrogated
in mutant Hepa 1C4 cells, and it was not observed in wild-type
Hepa 1 cells in assays using a reporter gene, pGLHIF1mt.3
(25), that contains three mutated copies of the HRE motif
(data not shown). Upon transient expression of either HIF-1a
or Arnt in HeLa cells, which express low levels of endogenous
Arnt (13a), pGLHIF1.3 reporter gene activity was stimulated
around two- to threefold under normoxic conditions (Fig. 3A),
presumably as a result of constitutive interaction of these over-
expressed factors with constitutively expressed endogenous
Arnt or HIF-1a, respectively. Moreover, coexpression of
HIF-1a and Arnt resulted in potent (around 30-fold) activa-
tion of the reporter gene (Fig. 3A). In control experiments, the
low levels of Arnt and dioxin receptor endogenous to HeLa
cells produced poor ligand inducibility of a transiently trans-
fected XRE-driven reporter gene construct, pTX.DIR (Fig.
3B). A strong, ligand-dependent activation response can be
reconstituted, however, upon coexpression of Arnt and dioxin
receptor (Fig. 3B) (33). Deletion of the basic domain of Arnt
yields a dominant negative mutant, ArntDb (Fig. 4A), that, like
the Id class of regulators of bHLH transcription factors (re-
viewed in reference 58), produces non-DNA-binding het-
erodimeric complexes with the ligand-activated dioxin receptor
(28). Coexpression of ArntDb and wild-type dioxin receptor in
HeLa cells resulted in complete inhibition of ligand-induced
activation of the XRE reporter gene (Fig. 3B). In a similar
fashion, ArntDb inhibited function of HIF-1a on the HRE-
driven reporter gene (Fig. 3A), further demonstrating that
Arnt is critical for the HRE-mediated induction response. In-
terestingly, we observed low levels of residual HIF-1a-depen-
dent functional activity on the HRE-driven reporter gene (Fig.
3A) at a dose of the dominant negative ArntDb mutant which
completely inhibited dioxin receptor function (Fig. 3B), possi-
bly suggesting that HIF-1a formed a stronger complex than the
dioxin receptor with the low levels of endogenously expressed
Arnt in these cells.
Arnt requires both the bHLH and PAS motifs to interact
with HIF-1a. We next analyzed dimerization properties of
HIF-1a with wild-type or mutant Arnt proteins (shown sche-
matically in Fig. 4A) upon in vitro translation in rabbit reticu-
locyte lysate, and equal concentrations (Fig. 4B; compare lanes
7 to 10) of proteins were subsequently used in coimmunopre-
cipitation experiments. As expected, [35S]methionine-labeled
HIF-1a was coimmunoprecipitated with specific polyclonal an-
tibodies against Arnt following incubation with nonlabeled,
wild-type Arnt, whereas the Arnt antibodies precipitated only
very low background levels of HIF-1a in the absence of Arnt
(Fig. 4B; compare lanes 1 to 3). No dimerization between Arnt
and HIF-1a was detected with the ArntDPAS and Arnt
DbHLH deletion mutants that lack the bHLH and PAS do-
mains, respectively (Fig. 4B; compare lanes 2 to 5). Thus,
consistent with the mode of interaction of Arnt with the ligand-
activated dioxin receptor (28, 66), both the bHLH and and
PAS domains of Arnt were critical for dimerization with HIF-
1a. In contrast, deletion of the basic domain in the ArntDb
mutant did not affect the dimerization activity with [35S]methi-
onine-labeled HIF-1a (Fig. 4B; compare lanes 2 and 6).
In these coimmunoprecipitation experiments, HIF-1a exhib-
ited very high affinity for Arnt. We therefore compared the
dimerization activity of Arnt with HIF-1a with the interaction
between Arnt and the ligand-activated dioxin receptor. Equal
concentrations of either [35S]methionine-labeled HIF-1a or
[35S]methionine-labeled, dioxin-activated dioxin receptor were
incubated with identical concentrations of in vitro-translated
unlabeled Arnt prior to immunoprecipitation with Arnt anti-
bodies. Strikingly, up to 10-fold-higher levels of HIF-1a were
recovered in these experiments in comparison with the coim-
munoprecipitated levels of dioxin receptor (Fig. 4C), indicat-
ing a considerably higher affinity of Arnt for HIF-1a relative to
the dioxin receptor.
Functional interference between hypoxia and dioxin signal-
ling pathways. Given the high affinity of HIF-1a for Arnt, we
wished to examine whether activation of HIF-1a would affect
functional properties of the ligand-induced dioxin receptor-
Arnt complex. Both hypoxia and CoCl2 induce DNA binding
activity of the HIF-1a–Arnt complex and induce transcription
of target genes, e.g., the EPO gene, via the HRE motif (ref-
erence 56 and references therein). Cells of hepatic origin are
generally both dioxin and hypoxia inducible. For instance, hu-
man HepG2 hepatoma cells are highly dioxin responsive (ref-
FIG. 4. Arnt requires both the bHLH and PAS motifs to interact with HIF-
1a. (A) Schematic representation of full-length Arnt and Arnt deletion mutants.
The bHLH and PAS motifs are indicated. (B) In vitro-translated [35S]methi-
onine-labeled full-length HIF-1a was incubated with equal concentrations of in
vitro-translated unlabeled full-length Arnt (lanes 1 and 2), the indicated Arnt
deletion mutants (lanes 4 to 6), or blank reticulocyte lysate (lane 3) as described
in Materials and Methods. Coimmunoprecipitation was carried out with Arnt-
specific antiserum (lanes 2 to 6) or preimmune control serum (P.I.S.; lane 1).
Resulting coimmunoprecipitated products were visualized by SDS-PAGE and
fluorography. Lanes 7 to 10 represent [35S]methionine-labeled control transla-
tions of full-length Arnt and Arnt deletion mutants. (C) Equal concentrations of
in vitro-translated [35S]methionine-labeled full-length HIF-1a (lanes 1 and 2)
and dioxin receptor (DR; lanes 3 and 4) were incubated with 5 ml in vitro-
translated unlabeled full-length Arnt (lanes 2 and 4) or blank reticulocyte lysate
(lanes 1 and 3) as described in Materials and Methods. Coimmunoprecipitation
was carried out with Arnt-specific antiserum, and the precipitated material was
analyzed as described above. Lanes 5 and 6 represent control in vitro translations
of full-length HIF-1a and dioxin receptor in the presence of [35S]methionine.
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erence 15 and references therein) and show induction of EPO
expression and DNA binding activity of HIF-1 by hypoxia and
treatment with CoCl2 (reference 60 and references therein).
To study the effect of CoCl2 treatment on dioxin receptor-
mediated transcription, we transiently transfected HepG2 cells
with a minimal reporter gene construct driven by a tandem of
XREs. As shown in Fig. 5A, transcription of this reporter gene
is strongly induced by exposure of the cells to the dioxin re-
ceptor ligand TCDF, whereas treatment of the cells with CoCl2
did not affect promoter activity. Furthermore, neither treat-
ment affected the basal activity of the parental reporter gene,
pT81. Strikingly, however, dioxin receptor ligand responsive-
ness of the XRE-containing promoter was significantly re-
pressed following coincubation of the cells with TCDF and
CoCl2 (Fig. 5A).
Consistent with the mode of regulation of HIF-1a mRNA
expression levels by hypoxic treatment of Hepa 1 cells (Fig.
2B), HIF-1a mRNA steady-state levels were not induced fol-
lowing exposure of HepG2 cells to CoCl2 but rather slightly
(;2-fold) down-regulated (Fig. 5B). In control experiments,
mRNA expression levels of the hypoxia-inducible aldolase A
and EPO genes were elevated in response to CoCl2 treatment
of HepG2 cells (Fig. 5B). Relative to b-actin control mRNA
levels, no effect of TCDF treatment on the basal expression
level of either HIF-1a, aldolase A, or EPO mRNA was ob-
served, nor did exposure to TCDF affect induction of aldolase
A or EPO mRNA expression levels by CoCl2 (Fig. 5B). Thus,
although treatment of HepG2 cells with CoCl2 impaired dioxin
receptor function, the reverse effect was not observed; i.e.,
CoCl2 responsiveness was not affected by the dioxin receptor
ligand TCDF.
The cytochrome P-4501A1 gene is a well-characterized tar-
get gene of the dioxin receptor. Upon exposure to TCDF, a
massive induction response is observed in HepG2 cells, as
assessed by RNA blot analysis (Fig. 5C). Following pretreat-
ment of the cells with CoCl2 for 16 h prior to administration of
TCDF for an additional 8 h, the TCDF induction response was
reduced about twofold relative to b-actin control mRNA levels
(Fig. 5C).
The inhibitory effect of CoCl2 on ligand-dependent induc-
tion of the XRE-driven reporter gene and cytochrome
P-4501A1 induction suggests that activation of HIF-1a may
result in interference with dioxin receptor-mediated transcrip-
tional regulation. To establish the role of HIF-1a in negative
regulation of dioxin receptor function, we transiently expressed
HIF-1a in HepG2 cells and monitored ligand-dependent acti-
vation of the cotransfected XRE-driven reporter gene con-
struct. In the presence of the empty pCMV expression vector,
we observed bona fide levels of induction of reporter gene
activity by TCDF. Upon expression of HIF-1a, however, the
ligand-dependent induction response was dramatically down-
regulated (Fig. 6), demonstrating that HIF-1a interfered with
dioxin receptor-mediated regulation of the reporter gene. In
these experiments, CoCl2 treatment was not required to inhibit
TCDF responsiveness by HIF-1a. Thus, overexpression of
HIF-1a resulted in constitutive HIF-1a activity. In agreement
with these observations, overexpression of HIF-1a and Arnt
individually or in combination resulted in constitutive activa-
tion of an HRE-driven reporter gene (Fig. 3A). In a similar
fashion, transient overexpression of the dioxin receptor in cer-
tain cells yields constitutive active dioxin receptor-Arnt com-
plexes (34).
The DNA binding activity of the dioxin receptor is repressed
by CoCl2 treatment. To further examine the effect of CoCl2 on
dioxin receptor function, we analyzed the XRE binding activity
of the activated dioxin receptor-Arnt complex in nuclear ex-
tracts of HepG2 cells treated with TCDF in the absence or
presence of CoCl2. The DNA binding activity of the dioxin
FIG. 5. Inhibition of dioxin responsiveness by CoCl2 treatment of HepG2 cells. (A) HepG2 cells were transfected with the parental reporter gene pT81 or the
XRE-containing reporter pTX.DIR, as indicated. Luciferase activity was monitored from cells treated with 50 nM TCDF in the absence or presence of 150 mM CoCl2
for 48 h. Each error bar represents the standard deviation from three independent experiments. Cell extracts were normalized with regard to the protein content. TK,
thymidine kinase promoter. (B) Northern blot analysis of HIF-1a, aldolase A (ALDA), EPO, and b-actin mRNA levels in HepG2 cells. The cells were treated with
either vehicle alone (lane 1) or 50 nM TCDF for 8 h (lane 2). The cells were also pretreated with 150 mM CoCl2 for 16 h prior to addition of TCDF (lane 3) and
incubation for an additional 8 h or treated with CoCl2 alone for 24 h (lane 4). (C) Inhibition of P-4501A1 mRNA induction by CoCl2. HepG2 cells were treated with
solvent alone (lane 1), 50 nM TCDF for 8 h (lane 2), or 150 mM CoCl2 for 16 h (lane 4). In lane 3, cells were treated with 150 mM CoCl2 for 16 h prior to addition
of TCDF for an additional 8 h.
5226 GRADIN ET AL. MOL. CELL. BIOL.
receptor was monitored by an electrophoretic mobility shift
assay. In nontreated cells, no XRE binding activity by the
dioxin receptor was detected. Upon exposure of the cells to
TCDF for 1 h, the receptor generated a distinct complex with
the XRE probe (Fig. 7; compare lanes 1 and 2). This complex
was specific for the receptor, since its formation could be
inhibited by polyclonal dioxin receptor antibodies (data not
shown) or by an excess of the unlabeled XRE probe but not by
an excess of an unrelated sequence motif (Fig. 7; compare
lanes 7 and 8). Treatment of the cells with CoCl2 alone did not
have any effect on the XRE binding activity of the receptor
(lane 6). In contrast, pretreatment of HepG2 cells with CoCl2
for increasing periods of time prior to addition of TCDF re-
sulted in a marked decrease in XRE complex formation by the
TCDF-activated dioxin receptor (Fig. 7; compare lanes 2 to 5).
For reference, the DNA binding activity of the bHLH/leucine
zipper transcription factor USF (16) to the symmetric E-box
motif from the adenovirus major late promoter was unaffected
by the TCDF or CoCl2 treatment (Fig. 7; compare lanes 9 to
14) and therefore served as a control for the quality of the
nuclear extracts. Thus, the XRE binding activity of the nuclear
dioxin receptor was repressed in response to treatment of
HepG2 cells with CoCl2.
The ligand-activated dioxin receptor and HIF-1a compete
for recruitment of the Arnt partner factor.We have previously
demonstrated that the ligand-activated dioxin receptor re-
quires recruitment of Arnt in order to recognize the XRE
target sequence. Individually, neither the dioxin receptor nor
Arnt binds to this sequence motif (66). Since XRE binding
activity of the ligand-activated dioxin receptor was down-reg-
ulated by CoCl2 treatment, and in view of the very stable
complexes that were formed between HIF-1a and Arnt in
vitro, we wished to investigate whether dioxin receptor and
HIF-1a would compete for recruitment of the common part-
ner factor Arnt. To this end, we performed coimmunoprecipi-
tation experiments using Arnt, dioxin receptor, and HIF-1a
proteins expressed in rabbit reticulocyte lysate. We first mon-
itored dioxin receptor-Arnt dimerization by incubating [35S]
methionine-labeled dioxin receptor and in vitro-translated, un-
labeled Arnt in the absence or presence of dioxin, followed by
immunoprecipitation with polyclonal antibodies against Arnt.
As expected, this assay reconstituted ligand-dependent inter-
action between the receptor and Arnt (66) (Fig. 8A; compare
lanes 1 and 2). In the presence of increasing concentrations of
in vitro-translated, unlabeled HIF-1a, however, coprecipita-
tion of the ligand-activated, [35S]methionine-labeled dioxin re-
ceptor was reduced in a concentration-dependent manner (Fig.
8A; compare lanes 2 to 5). Conversely, upon incubation of
[35S]methionine-labeled HIF-1a and unlabeled Arnt, precipi-
tation of labeled HIF-1a by the Arnt antibodies was not af-
fected by exposure to increasing concentrations of in vitro-
translated, ligand-activated dioxin receptor (Fig. 8B; compare
lanes 1 to 4). These concentrations of dioxin receptor were
identical to the concentrations of HIF-1a that interfered with
dioxin receptor-Arnt dimerization. These results indicate that
HIF-1a competed with the ligand-activated dioxin receptor for
recruitment of the Arnt partner factor. In agreement with the
higher affinity of HIF-1a for Arnt, the ligand-activated dioxin
receptor failed to disrupt the HIF-1a–Arnt complex at the
FIG. 6. Inhibition of dioxin receptor function by overexpression of HIF-1a.
HepG2 cells were transiently cotransfected with the parental pT81 or the XRE-
containing pTX.DIR reporter plasmids together with the HIF-1a expression
plasmid pHIF-1a/CMV4 or an empty pCMV4 vector. Luciferase activity was
assayed 48 h after transfection. Each bar represents the standard deviation of the
relative luciferase activity from three independent experiments, with values nor-
malized relative to the protein content of each extract.
FIG. 7. The DNA binding activity of the dioxin receptor is down-regulated
upon exposure to CoCl2. An electrophoretic gel mobility shift assay was per-
formed with nuclear extract prepared from either untreated HepG2 cells (lanes
1 and 9) or HepG2 cells treated with 50 nM TCDF alone for 1 h (lanes 2, 7, 8,
and 10). Cells were also pretreated with 150 mM CoCl2 at different time points
prior to addition of TCDF for 1 h (lanes 3 to 5 and 11 to 13) or treated with 150
mM CoCl2 alone for 4 h (lanes 6 and 14). Equal amounts of protein from the
different nuclear extracts were incubated with 32P-labeled oligonucleotides, and
the extracts were analyzed for dioxin receptor-dependent (lanes 1 to 8) or
USF-dependent (lanes 9 to 14) DNA binding activities. Competition experi-
ments were performed by including a 100-fold excess of unlabeled probe (Spec.;
lane 8) or an unrelated oligonucleotide (Unspec.; lane 7). The mobilities of the
dioxin receptor (DR)- and USF-dependent DNA-protein complexes are indi-
cated. Unbound probe is indicated as free probe, and the asterisks indicate
complexes generated by constitutive XRE-specific factors.
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tested concentrations (up to a twofold molar excess of dioxin
receptor over HIF-1a).
HIF-1a is associated with the molecular chaperone hsp90.
We have previously observed that the non-DNA-binding, re-
pressed form of dioxin receptor is associated with hsp90 (68)
and that hsp90 is important for folding of a ligand-binding
conformation of the receptor in vitro (10, 44). Importantly,
ligand responsiveness of the dioxin receptor is abrogated in a
yeast model system following down-regulation of hsp90 expres-
sion levels (8, 65). Taken together, these data strongly argue
that hsp90 is critical for conditional regulation of dioxin recep-
tor function. Moreover, we have recently demonstrated that
hsp90 also is associated with the Drosophila bHLH/PAS factor
Sim (35), to which HIF-1a shows a high degree of similarity
(56). Given this background, we wished to test whether HIF-1a
was associated with hsp90. HIF-1a was expressed and [35S]me-
thionine labeled by in vitro translation in reticulocyte lysate,
and we performed coimmunoprecipitation experiments using a
monoclonal hsp90 antibody, 3G3, that specifically recognizes
both free hsp90 and hsp90 complexed with other proteins (39).
These antibodies coimmunoprecipitate the dioxin receptor
upon de novo synthesis in reticulocyte lysate (36, 63). We
observed that the hsp90 antibodies also coimmunoprecipitated
in vitro-translated, [35S]methionine-labeled HIF-1a (Fig. 9,
lane 1). In control reactions, only very low levels of labeled
HIF-1a were detected following precipitation with irrelevant
monoclonal antibodies (Fig. 9; compare lanes 1 and 2). Thus,
these experiments demonstrated stable interaction of HIF-1a
with hsp90. Although the functional significance of this inter-
action remains to be elucidated, the importance of hsp90 for
conditional regulation of dioxin receptor activity suggests that
a similar mechanism may modulate HIF-1a function. In sup-
port of this notion, the present data demonstrate that HIF-1a
was constitutively expressed in a large number of tissues (Fig.
1), and, in contrast to the prevalent model of regulation of
HIF-1a in Hep3B cells, HIF-1a mRNA expression levels were
not upregulated in Hepa 1 following exposure to hypoxia (Fig.
2B) or in HepG2 cells in response to CoCl2 treatment (Fig.
5B). Moreover, given the strict correlation between ligand and
hsp90 binding activities of the dioxin receptor (10, 63), it will
be interesting to examine the possibility that HIF-1a can bind
an as yet unknown class of ligands and thus constitute a so-
called orphan receptor.
DISCUSSION
In this study, we have demonstrated that Arnt is required for
HIF-1a function. Thus, the ubiquitously expressed Arnt pro-
tein is involved in regulation of expression of multiple net-
works of target genes. Through heterodimerization with either
the dioxin receptor or HIF-1a, it is required for recognition of
cognate asymmetric E-box target sequences and thereby criti-
cal for conditional gene regulation of target genes by dioxin or
hypoxia and CoCl2, respectively. Moreover, Arnt has recently
been reported to homodimerize in vitro (18, 53) and constitu-
tively bind the E-box motif CACGTG and regulate reporter
gene expression in vivo by the same E-box element (2, 53).
Consistent with a critical role of Arnt as a coregulator pro-
tein serving to target HIF-1a to its cognate response element,
a dominant negative Arnt mutant inhibited HIF-1a function
on minimal reporter genes driven by the EPO HRE motif.
Moreover, induction of aldolase A mRNA levels was inhibited
in hypoxic Hepa 1C4 cells expressing functionally deficient
Arnt protein. Interestingly, however, hypoxic induction of
VEGF mRNA expression was only partially inhibited in the
mutant Hepa 1C4 subline. Thus, in agreement with the re-
cently proposed posttranscriptional mechanism of hypoxic reg-
ulation of VEGF expression (21, 26, 51), there may exist an
alternative pathway of hypoxic regulation that is independent
of the HIF-1a–Arnt complex.
Cross-coupling of HIF-1a- and dioxin receptor-mediated
regulatory pathways. The data presented here indicate that
HIF-1a, once activated, dominates over the ligand-stimulated
dioxin receptor for recruitment of Arnt, resulting in interfer-
ence between hypoxia and dioxin signalling pathways. For ex-
ample, in dioxin- and hypoxia-responsive human HepG2 cells,
dioxin receptor function was impaired in cells cotreated with
dioxin receptor ligand and CoCl2. Under these conditions,
Arnt therefore appeared to be limiting for dioxin responsive-
ness. This model is supported by the observation that the DNA
binding activity of the dioxin receptor was inhibited in nuclear
extracts of HepG2 cells exposed to both dioxin and CoCl2.
Moreover, HIF-1a exhibited an affinity for Arnt in vitro that
was considerably higher than that of the ligand-activated dioxin
receptor. HIF-1a could therefore efficiently compete with the
ligand-activated dioxin receptor for dimerization with Arnt in
vitro. Conversely, at all tested excess concentrations of acti-
vated dioxin receptor over HIF-1a, the dioxin receptor did not
compete with HIF-1a for recruitment of Arnt. Thus, although
FIG. 8. HIF-1a competes with the ligand-activated dioxin receptor for re-
cruitment of the Arnt partner factor. (A) In vitro-translated [35S]methionine-
labeled full-length dioxin receptor was incubated with 5 ml of unlabeled in
vitro-translated full-length Arnt in the presence (lanes 2 to 5) or absence (lane
1) of 10 nM dioxin (TCDD). The ligand-activated dioxin receptor was also
incubated without (lanes 1 and 2) or with a 0.5-fold (lane 3), 1-fold (lane 4), or
2-fold (lane 5) molar excess of unlabeled in vitro-translated full-length HIF-1a as
described in Materials and Methods. Coimmunoprecipitation was carried out
with Arnt-specific antiserum, and the coimmunoprecipitated products were vi-
sualized by SDS-PAGE and fluorography. (B) In vitro-translated [35S]methi-
onine-labeled full-length HIF-1a was incubated with 5 ml of unlabeled in vitro-
translated full-length Arnt in the absence or presence of increasing
concentrations of unlabeled dioxin receptor (DR) and then coimmunoprecipi-
tated with Arnt-specific antiserum. The products were analyzed as described
above. The concentration of [35S]methionine-labeled HIF-1a was equivalent to
that of [35S]methionine-labeled dioxin receptor in panel A.
FIG. 9. HIF-1a is associated with the molecular chaperone hsp90. Full-
length HIF-1a cDNA was in vitro translated in the presence of [35S]methionine
in rabbit reticulocyte lysate, coimmunoprecipitated with hsp90-specific (S; lane
1) or control immunoglobulin M (C; lane 2) antibody as described in Materials
and Methods, and analyzed by SDS-PAGE and fluorography.
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HIF-1a inhibited dioxin receptor function by sequestering
Arnt, dioxin and hypoxia signalling pathways were not mutu-
ally exclusive. Inasmuch as HIF-1a mRNA expression patterns
were largely correlated with Arnt mRNA expression levels in a
number of human tissues, and, in turn, Arnt expression levels
are largely correlated with those of the dioxin receptor (7), it
will now be interesting to examine whether activation of the
HIF-1a signalling pathway generally interferes with dioxin re-
ceptor function. Given the high affinity of HIF-1a for Arnt, the
present data also raise the possibility that functional interac-
tion of Arnt with other bHLH/PAS partner factors, in addition
to the dioxin receptor, is negatively regulated by the activated
form of HIF-1a. In this context, one interesting candidate
partner factor is represented by mammalian homologs of Dro-
sophila Sim, e.g., the putative Down’s syndrome-critical factor
(11). Drosophila Sim has recently been shown to dimerize with
Arnt and to require Arnt for DNA binding activity (35, 53, 55,
62).
Combinatorial regulation of either HIF-1a or dioxin recep-
tor activity by interaction with the Arnt partner factor may
create the basis for very complex and possibly cell type-specific
patterns of modulation of HIF-1a and dioxin receptor func-
tion. For instance, given the growing family of bHLH/PAS
factors and the strikingly complex regulatory networks of other
bHLH factors, it is possible that Arnt functionally interacts
with additional, as yet unidentified partner factors. Since Dro-
sophila Sim recently has been shown to dimerize with Arnt (35,
53, 55), among the interesting putative partner factors of Arnt
are mammalian homologs of Sim, notably the Down’s syn-
drome-critical factor (11). Thus, putative partner factors of
Arnt may be found in developmental regulatory pathways,
resulting in possibly novel phenomena of cross-coupling with
dioxin receptor and HIF-1a-mediated signalling processes.
The present experiments indicate that under conditions in
which Arnt is limiting, the efficiency of Arnt-partner factor
interaction constitutes a critical step in regulation of the activ-
ity of the two conditionally regulated bHLH/PAS factors
HIF-1a and dioxin receptor. In conclusion, these data argue
that the level of expression of Arnt or the pool of Arnt avail-
able for dimerization with the dioxin receptor represents an
important mechanism for determining cellular sensitivity and
responsiveness to dioxin.
Mechanism of activation of HIF-1a.What is the mechanism
of conditional regulation of HIF-1a function by hypoxia or
CoCl2? In this study, we observed constitutive expression levels
of HIF-1a mRNA that mirrored those of Arnt in a variety of
tissues. In agreement with these data, HIF-1a mRNA levels
remain unaltered in all organs examined of carbon monoxide-
exposed mice, which show strong induction of serum EPO
levels (61). Moreover, constitutive expression of HIF-1a
mRNA was observed in several cell lines, including human
HepG2 and murine Hepa-1 hepatoma cell lines. In contrast,
both HIF-1a and Arnt mRNA have been reported to be ex-
pressed at very low constitutive levels in human Hep3B cells
(56). Importantly, exposure of HepG2 or Hepa-1 cells to hy-
poxia or CoCl2 did not induce HIF-1a mRNA expression lev-
els but rather resulted in down-regulation of the mRNA levels.
This result contrasts sharply with that for Hep3B cells, in which
a dramatic induction of HIF-1a mRNA levels by hypoxia or
CoCl2 has recently been found (56). Induction of HIF-1a
mRNA expression is therefore not likely to represent a more
general mechanism for activation of HIF-1a function. Rather,
the present data suggest that regulation of HIF-1a function
involves a posttranscriptional mechanism.
The present experiments demonstrate that de novo-synthe-
sized HIF-1a stably associates in vitro with the molecular chap-
erone hsp90. We do not yet know whether hsp90 is capable of
mediating repression of HIF-1a function in nonstimulated tar-
get cells. It also remains to be established whether interaction
with hsp90 is important for folding of a functional form of
HIF-1a, consistent with the role of hsp90 as a molecular chap-
erone (37, 67). Previous data indicate that hsp90 is critical for
ligand inducibility in vivo not only of the dioxin receptor (8, 65)
but also of distinct nuclear receptors such as the glucocorticoid
receptor (5, 40). In the cases of both the dioxin receptor (44,
68, 64) and the glucocorticoid receptor (reviewed in references
45 and 52), release of hsp90 appears to be required for un-
masking of functional activity, since only the repressed, non-
DNA-binding forms of the receptors show interaction with
hsp90. In agreement with these findings, a domain of the dioxin
receptor that mediates an inhibitory function in vivo is stably
associated with hsp90 in vitro (31, 64). Moreover, artificial
disruption of hsp90 in vitro results in constitutive DNA binding
activity of the dioxin receptor (44), most probably as a result of
constitutive dimerization with Arnt. It is therefore conceivable
that dissociation of hsp90 results in unmasking of the dimer-
ization interface of HIF-1a, subsequent recruitment of Arnt,
and derepression of HIF-1a function.
In contrast to HIF-1a and the dioxin receptor, Arnt is not
associated with hsp90 (36). These data reinforce the idea that
only conditionally regulated transcription factors, e.g., dioxin
receptor, HIF-1a, and certain members of the nuclear hor-
mone receptor family, are associated with hsp90, whereas this
interaction is not detected with constitutively active transcrip-
tion factors. In the case of the dioxin receptor, hsp90 appears
to chaperone a ligand-binding conformation of the receptor,
since following release of hsp90, the dioxin receptor fails to
bind ligand (2, 44). Consistent with these observations, the
bacterially expressed minimal ligand binding domain of the
receptor appears to be malfolded and shows no ligand binding
activity (10). Given the correlation between association with
hsp90 and ligand binding function of the dioxin receptor, and
the importance of hsp90 for ligand binding activity of the
glucocorticoid receptor (reviewed in references 45 and 52), it is
possible that HIF-1a represents an intracellular orphan recep-
tor for an as yet unknown class of ligands. Thus, in addition to
the growing number of orphan receptors within the steroid
receptor superfamily (see reference 32 for a review), certain
bHLH/PAS factors may represent a novel and distinct class of
orphan receptors. Such receptors offer the potential for accu-
rate conditional regulation of functional activities. In summary,
it is tempting to speculate that hsp90 may be important for the
maintenance and/or folding of a repressed form of HIF-1a and
that this provides both the regulation and signal-sensing mech-
anism necessary for the hypoxia-controlled process.
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